Incidence and mortality rates of kidney cancers in Iran compared to its proportion throughout the world

Author:

Goodarzi Elham1,Dehghani Seyedeh Leila2,Khazaei Zaher3

Affiliation:

1. Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran

2. Behbahan Faculty of Medical Sciences, Behbahan, Iran

3. MSc in Epidemiology, Student Research Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran

Abstract

Introduction: Kidney cancer was considered as the ninth common cancer worldwide. Its incidence and mortality has been increasing for decades. However, in recent years in many countries, there is a downward trend. Objectives: This study sought to evaluate the incidence and mortality rates of renal cancers in Iran compared to its proportion throughout the world. Materials and Methods: All mortality and incidence rates of all countries were extracted from the Global Cancer Project (GLOBOCAN) (data of 2012). The methods of estimation were quality of the estimation and country-specific that was dependent on the quality and on the amount of the available data of each country. Results: The rates have been shown in eight categories; world, very high human development, high human development, medium human development, low human development, less developed, more developed regions in addition to Iran. The rates of Iran were close to medium human developed region rates. In Iran, 1641 kidney cancers cases have been registered which 981 men and 660 women were reported with an overall incidence rate of 1.9 per 100 000 which is less than world incidence rate for kidney cancers. In Iran, the highest incidence was also among patients with age of 75 years and more. Additionally, the lowest incidence rates were among age groups of less than 15 years and age group of 45- 49 years. Conclusion: Considering the lower incidence and mortality rates of kidney cancer in Iran compared to other regions of the world, conducting more studies to find related-risk factors to decline the incidence rates of disease would be necessary.

Publisher

Maad Rayan Publishing Company

Subject

Pharmacology (medical),Nephrology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3